ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression

Signal Transduct Target Ther. 2023 Mar 18;8(1):130. doi: 10.1038/s41392-023-01395-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / pathology
  • Nuclear Proteins / genetics
  • RNA
  • RNA-Binding Proteins / genetics
  • Transcription Factors / genetics

Substances

  • RNA
  • Transcription Factors
  • Nuclear Proteins
  • ALYREF protein, human
  • RNA-Binding Proteins